Eli Lilly makes both the dual-agonist and triple-agonist drugs
Individuals with certain skin conditions, like eczema, psoriasis, dermatitis, or severe scarring, might be recommended by their healthcare professional to avoid transdermal patches as their skin condition may worsen or influence drug delivery
GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas
Know low blood sugar signs and coordinate dosing
The median time over which the participants health was followed was about 6 years for the GLP-1 group and about 5 years for the aspirin group
I simply was not hungry